BSE filing, NSE: NOL. Summary written from the filing by ALFA Finder's alert engine.
National Oxygen Ltd: key numbers
- Share price
- ₹58.50
- Market cap
- ₹29.50 Cr
- Revenue (annual)
- ₹22.96 Cr
- Net profit (annual)
- ₹1.84 Cr
- P/E (TTM)
- 17.4×Sector 51.6×
- Promoter holding
- 63.67%-1.89% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from National Oxygen Ltd
All →National Oxygen Q2 FY27 Results: Net Loss of ₹1.7 Cr
National Oxygen Ltd approved unaudited standalone results for the quarter ended 30 September 2026, with a net loss of Rs 174.36 lakh for the quarter. Year-to-date results show a loss of Rs 375.01 lakh.
- Key figure
- Net loss ₹1.7 Cr
National Oxygen Board Meeting Date
National Oxygen's board meets on 13 November 2026 to consider unaudited quarterly results for the quarter ended 30 September 2026. This is an advance intimation, so the outcome is not yet known.
National Oxygen Other Announcement
National Oxygen filed its September 2026 quarter shareholding pattern. Promoter entry changed only due to an entity's LLP conversion.
National Oxygen Other Announcement
National Oxygen Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
National Oxygen Annual General Meeting
National Oxygen Limited held its 51st Annual General Meeting on August 28, 2026. All listed resolutions were passed with the requisite majority by the members.
National Oxygen Q1 FY27 Results: Net Loss of ₹2 Cr, Loss Widens
National Oxygen Ltd reported revenue from operations of ₹3 Cr (-60.5% YoY) and a net loss of ₹2 Cr for Q1 FY27.
- Key figure
- Net loss ₹2 Cr
Other other announcement announcements
All →Kratikal Tech Other Announcement
Kratikal Tech submitted CARE Ratings' Monitoring Agency Report for the quarter ended 30 September 2026. It confirms IPO proceeds were used as per the offer document, with no deviation.
Procter & Gamble Health Other Announcement
Procter & Gamble Health intimated that its RTA, KFin Technologies, is moving its corporate office from December 1, 2026. The company's registered office is unchanged.
Tradewell Holdings Other Announcement
Tradewell Holdings confirmed Regulation 23(9) related party disclosures do not apply for the half year ended September 2026. Paid-up capital and net worth sit below thresholds.
S & T Corporation Other Announcement
S&T Corporation reports Reg 23(9) related-party disclosures are not required this half year. Net worth and paid-up capital fall below the small-entity threshold.
Godrej Industries Other Announcement
Godrej Industries filed a nil security cover certificate for its unsecured NCDs. It is routine compliance with no new debt or money involved.
Muthoot Microfin Other Announcement
Muthoot Microfin submitted its provisional Asset Liability Management statement for October 2026 under the SEBI circular. It is a routine periodic regulatory return with no new transaction.